The mission of the International Thyroid Oncology Group is to catalyze a cure for the most challenging thyroid cancers through the collaborative efforts of our unique multidisciplinary team of leading physicians, scientists, and advocates to design, coordinate, and prioritize state-of-the-art clinical trials and correlative science.
Our members have led paradigm changing clinical trials for thyroid cancer patients. These trials have already resulted in the FDA approval of two new drugs for medullary thyroid cancer, and innovative new approaches for treating differentiated thyroid cancer. We are doctors, scientists, and patients whose lives and careers are focused on identifying new therapies for thyroid cancer.
ITOG is building on the success of our members by forging collaborative efforts that can accelerate drug discovery and clinical trials. These efforts require your involvement. You can help us catalyze a cure by making a financial contribution to ITOG, a 501(c)(3) tax-exempt public charity; your contribution may be tax deductible.